Troculeucel clinical trials
Also written Natural killer cells and SNK01.
How each study uses troculeucel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the troculeucel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
41 studies that test it; most in 2016 (25)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 25 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 4 |
| 2023 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 34
Fuda Cancer Hospital, Guangzhou (25) · NKGen Biotech, Inc. (6) · Masonic Cancer Center, University of Minnesota (5) · Hospital de Clinicas de Porto Alegre (2) · St. Jude Children's Research Hospital (1) · Monica Thakar (1) · NKMAX Co., Ltd. (1)
Often tested with
Tested in the same studies.
Antineoplastic Agents (1) · Interleukin-2 (1) · Anti-EGFR/CD16A Bispecific Antibody AFM24 (1)
Studies
Open first, then newest update. How each study uses troculeucel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 41
- Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseaseRecruitingPhase 1/2NKGen Biotech, Inc.NCT06189963Written as SNK01
- Open-Label Extension Protocol to SNK01-AD01 StudyRecruitingPhase 2NKGen Biotech, Inc.NCT07228078Written as SNK01
- Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid TumorsTerminatedPhase 2Monica ThakarNCT02100891Written as Donor NK Cell Infusion
- Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing CancersTerminatedPhase 1/2NKGen Biotech, Inc.NCT05099549Written as SNK01
- Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)TerminatedPhase 1NKGen Biotech, Inc.NCT04678453Written as SNK01
- Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional TherapyCompletedPhase 1NKGen Biotech, Inc.NCT03941262Written as SNK01
- A Study to Evaluate the Safety and Anti-tumor Activity of SNK01 (NK Cells) Administered in Combination With Chemotherapy or Chemotherapy / Cetuximab in Local Advanced or Metastatic Non-small Cell Lung Cancer Patients Who Failed Tyrosine Kinase Inhibitor TreatmentStatus unknownPhase 1/2NKMAX Co., Ltd.NCT04872634Written as SNK01 (Super Natural Killer Cells 01)
- Fase I Clinical Trial on NK Cells for COVID-19Status unknownPhase 1Hospital de Clinicas de Porto AlegreNCT04634370Written as Natural Killer Cells infusion
- Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid TumorsCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02857920Written as NK immunotherapy
- Autologous Natural Killer Cells in Subjects With Plaque PsoriasisCompletedPhase 1NKGen Biotech, Inc.NCT03894579Written as Study Product: SNK01
- Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid TumorsCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02843204Written as NK immunotherapy
- Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid LeukemiaStatus unknownPhase 1/2Hospital de Clinicas de Porto AlegreNCT02809092Written as NK Cells + Chemotherapy Starting
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02849340Written as NK immunotherapy
- Combination of Cryosurgery and NK Immunotherapy for Recurrent SarcomaCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02849366Written as NK immunotherapy
- Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02843126Written as NK immunotherapy
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02849327Written as NK immunotherapy
- High-activity Natural Killer Immunotherapy for Small Metastases of Tongue CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT03008330Written as High-activity natural killer
- High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT03008304Written as High-activity natural killer
- Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02844335Written as NK immunotherapy
- Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal CancerCompletedPhase 1/2Fuda Cancer Hospital, GuangzhouNCT02843581Written as NK immunotherapy
See all 41 studies that test troculeucel →
Given beside what is tested · 4 — troculeucel is usual care or a partner of the new treatment
- NK Cells Infusions With Irinotecan, Temozolomide, and DinutuximabActive, not recruitingPhase 1/2Nationwide Children's HospitalNCT04211675Written as Natural Killer Cells
- Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerSuspendedPhase 1David WaldNCT05400122Written as Natural Killer Cells
- Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803CompletedPhase 1Brenda Cooper, MDNCT02890758Written as Natural Killer (NK) Cells
- Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWithdrawnPhase 1/2NKGen Biotech, Inc.NCT04464967Written as SNK01
Codes
What other systems call troculeucel · ClinicalTrials.gg INT016883
- UNII (FDA) IZR558KO53TROCULEUCELOne source FDA
- NCI Thesaurus C178330TroculeucelOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | IZR558KO53 | TROCULEUCEL | One source FDA |
| NCI Thesaurus | C178330 | Troculeucel | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.